Abstract:Thioredoxin reductase (TrxR) in conjunction with thioredoxin (Trx) is a ubiquitous intracellular oxidoreductase system with antioxidant and redox regulatory roles. The properties of TrxR in combination with the functions of Trx position this system at the core of cellular thiol redox control and antioxidant defense. In some human tumors, the thioredoxin system is found over-expressed. Because of its role in stimulating cancer cell growth and as an inhibitor of apoptosis, the Trx system offers a target for the development of drugs to treat and prevent cancer. In a previous research, we successfully synthesized a novel organoselenium compound BBSKE(1,2-[bis(1,2-Benzisoselenazolone-3(2H)-ketone)]ethane, BBSKE, PCT: CN02/00412) targeting the TrxR, and it has demonstrated the inhibitory effect on the growth of a variety of human cancer cells from various organs. In this study, we investigated the inhibitory effect of BBSKE on TrxR activity in PC-3 and DU145 human prostate cancer cell lines, and its antitumoral effect on these two cell lines. Treatment of BBSKE inhibited the TrxR activity in both of the cell lines in a dose-dependent manner and it also inhibited the proliferation of these two cell lines in a dose-dependent manner. Cell cycle analysis showed S phase arrest in both of the cell lines following 48 h exposure to BBSKE. During the S arrest, analysis of cell cycle regulatory proteins demonstrated that BBSKE increased the protein levels of cyclinA, cyclinE, and P21, but decreased the levels of cyclinB1, cyclinD1, and Cdk4. Furthermore, BBSKE decreased the protein level of Bcl-2 but increased the level of Bax, and induced apoptosis in PC-3 and DU145 human prostate cancer cell lines. These results suggest that this novel TrxR inhibitor inhibits the proliferation of prostate cancer cells via S phase arrest and apoptosis in association with the regulation of multiple molecules in the cell cycle.

A Novel Thioredoxin Reductase Inhibitor Inhibits Cell Growth and Induces Apoptosis in HL-60 and K562 Cells

A thioredoxin reductase inhibitor induces growth inhibition and apoptosis in five cultured human carcinoma cell lines.

A Novel Organoselenium Compound Induces Cell Cycle Arrest and Apoptosis in Prostate Cancer Cell Lines.

The mechanism of apoptosis induced by a novel thioredoxin reductase inhibitor in A549 cells: Possible involvement of nuclear factor-κB-dependent pathway

Thioredoxin Reductase Inhibitor Ethaselen Inhibits Cancer Metastasis

Novel Thioredoxin Reductase Inhibitor Butaselen Inhibits Tumorigenesis by Down-Regulating Programmed Death-Ligand 1 Expression

Synergism Between Thioredoxin Reductase Inhibitor Ethaselen and Sodium Selenite in Inhibiting Proliferation and Inducing Death of Human Non-Small Cell Lung Cancer Cells.

Targeting thioredoxin reductase by eupalinilide B promotes apoptosis of colorectal cancer cells in vitro and in vivo

Targeting Thioredoxin Reductase By Plumbagin Contributes To Inducing Apoptosis Of Hl-60 Cells

The novel thioredoxin reductase inhibitor A-Z2 triggers intrinsic apoptosis and shows efficacy in the treatment of acute myeloid leukemia

SKLB-163, a new benzothiazole-2-thiol derivative, exhibits potent anticancer activity by affecting RhoGDI/JNK-1 signaling pathway

Differential Effects of Bexarotene on Intrinsic and Extrinsic Pathways in TRAIL-Induced Apoptosis in Myeloid Leukemia Cell Lines.

Biological Evaluation of Novel Selenazole-Based Compounds As Potential Thioredoxin Reductase Inhibitors

Synthesis of Naphthazarin Derivatives and Identification of Novel Thioredoxin Reductase Inhibitor As Potential Anticancer Agent

The Antimetastatic Effect and Underlying Mechanisms of Thioredoxin Reductase Inhibitor Ethaselen.

Natural Diterpenoid Eriocalyxin B Covalently Modifies Glutathione and Selectively Inhibits Thioredoxin Reductase Inducing Potent Oxidative Stress-Mediated Apoptosis in Colorectal Carcinoma RKO Cells.

Inhibitory Effects of Thioredoxin Reductase Antisense RNA on the Growth of Human Hepatocellular Carcinoma Cells

A novel benzothiazole derivative induces apoptosis via the mitochondrial intrinsic pathway producing antitumor activity in colorectal cancer.

Structural Modification of Aminophenylarsenoxides Generates Candidates for Leukemia Treatment Via Thioredoxin Reductase Inhibition

The Inhibitory Effect of A Novel Organoselenium Compound Bbske on the Tongue Cancer Tca8113 in Vitro and in Vivo

SKLB316, a Novel Small-Molecule Inhibitor of Cell-Cycle Progression, Induces G2/M Phase Arrest and Apoptosis in Vitro and Inhibits Tumor Growth in Vivo.